scholarly journals Is There a Correlation Between Behçet Disease and Lower Urinary Tract Symptoms?

2020 ◽  
Vol 24 (2) ◽  
pp. 150-155
Author(s):  
Aykut Baser ◽  
Ali Ersin Zumrutbas ◽  
Yusuf Ozlulerden ◽  
Okan Alkıs ◽  
Aynure Oztekın ◽  
...  
Keyword(s):  
Urinary Incontinence ◽  
Urine Volume ◽  
Activity Score ◽  
Behçet Disease ◽  
Behcet Disease ◽  
Residual Urine Volume ◽  
Urinary Tract Symptoms ◽  
Postvoid Residual Urine ◽  
The Mean ◽  
Lower Urinary

Purpose: In this study, we aimed to determine the prevalence of lower urinary tract symptoms (LUTS) in patients with Behçet disease (BD) and to investigate the relationship between the severity of BD and LUTS.Methods: Fifty-five patients with BD were included in this study from January to December 2018. All patients received a detailed urological evaluation. Additionally, BD activity was investigated using the Behçet Disease Current Activation Form. The International Prostate Symptom Score (IPSS), International Consultation on Incontinence Questionnaire Short Form, 8-item overactive bladder questionnaire forms, uroflowmetry, and postvoid residual urine volume were evaluated.Results: The mean age of the patients was 42.6 years. The mean activity score of BD was 4.6±3.2 and the mean IPSS score was 7.3±7.3. Sex had no significant effect on the BD activity score. The BD activity score was significantly correlated with the IPSS score, frequency of daytime urination, nocturia, and urgency. It was also correlated with the presence and the severity of urinary incontinence and the effect of urinary incontinence on daily life. Peak flow rate, voided volume, and the postvoid residual urine volume were not correlated with the BD activity score.Conclusions: LUTS were highly prevalent in patients with BD, and the severity and current activity of BD were correlated with frequency, nocturia, urgency, and urinary incontinence. Therefore, a urological evaluation of patients with BD in whom the activity and severity of the disease is elevated should be carried out comprehensively and patients should be managed accordingly.

scholarly journals The reliability and reproducibility of ultrasonography for measuring the residual urine volume in men with lower urinary tract symptoms

2014 ◽  
Vol 12 (4) ◽  
pp. 285-289 ◽  
Author(s):  
Hassan A. Abdelwahab ◽  
Housseini M. Abdalla ◽  
Mahmoud H. Sherief ◽  
Mohamed B. Ibrahim ◽  
Mostafa A. Shamaa
Keyword(s):  
Urinary Tract ◽  
Lower Urinary Tract Symptoms ◽  
Lower Urinary Tract ◽  
Urine Volume ◽  
Residual Urine Volume ◽  
Residual Urine ◽  
Urinary Tract Symptoms ◽  
Lower Urinary

scholarly journals The effectiveness of dried cranberries (Vaccinium macrocarpon) in men with lower urinary tract symptoms

2010 ◽  
Vol 104 (8) ◽  
pp. 1181-1189 ◽  
Author(s):  
Ales Vidlar ◽  
Jitka Vostalova ◽  
Jitka Ulrichova ◽  
Vladimir Student ◽  
David Stejskal ◽  
...  
Keyword(s):  
International Prostate Symptom Score ◽  
Lower Urinary Tract ◽  
Urine Volume ◽  
Vaccinium Macrocarpon ◽  
Control Group ◽  
C Reactive Protein ◽  
Residual Urine Volume ◽  
Reactive Protein ◽  
Urinary Tract Symptoms ◽  
Lower Urinary

Lower urinary tract symptoms (LUTS) are a common condition in older men. The objective of the present study was to evaluate the efficacy and tolerability of cranberry (Vaccinium macrocarpon) powder in men at risk of prostate disease with LUTS, elevated prostate-specific antigen (PSA), negative prostate biopsy and clinically confirmed chronic non-bacterial prostatitis. Forty-two participants received either 1500 mg of the dried powdered cranberries per d for 6 months (cranberry group;n21) or no cranberry treatment (control group;n21). Physical examination, International Prostate Symptom Score, quality of life (QoL), five-item version of the International Index of Erectile Function (IIEF-5), basic clinical chemistry parameters, haematology, Se, testosterone, PSA (free and total), C-reactive protein (CRP), antioxidant status, transrectal ultrasound prostate volume, urinary flow rate, ultrasound-estimated post-void residual urine volume at baseline, and at 3 and 6 months, and urineex vivoanti-adherence activity were determined in all subjects. In contrast to the control group, patients in the cranberry group had statistically significant improvement in International Prostate Symptom Score, QoL, urination parameters including voiding parameters (rate of urine flow, average flow, total volume and post-void residual urine volume), and lower total PSA level on day 180 of the study. There was no influence on blood testosterone or serum CRP levels. There was no statistically significant improvement in the control group. The results of the present trial are the first firm evidence that cranberries may ameliorate LUTS, independent of benign prostatic hyperplasia or C-reactive protein level.

scholarly journals Investigation of the Necessity of Urodynamic Test in Patients with Urinary Stress Incontinence for TOT Surgery

2020 ◽  
Vol 7 (1) ◽  
pp. 40-43
Author(s):  
Tahereh Poordast ◽  
Elham Askari ◽  
Fatemeh Sadat Najib ◽  
Shaghayegh Moradialamdarloo ◽  
Najmeh Naghizadeh
Keyword(s):  
Quality Of Life ◽  
Urinary Incontinence ◽  
Stress Incontinence ◽  
Transobturator Tape ◽  
Urinary Stress Incontinence ◽  
Additional Information ◽  
Urinary Tract Symptoms ◽  
The Mean ◽  
Lower Urinary

Background and aims: Stress urinary incontinence is one of the most common diseases which can reduce the quality of life in women. Urodynamic test is a common method of diagnosis of this disease. This study is designed for investigating the necessity of urodynamic test in patients with urinary stress incontinency before transobturator tape (TOT) surgery. Urodynamic test before surgery can affect the quality of life in patients. Methods: This study was a randomized clinical trial. The sample size was 48 patients divided into two groups of 24 women in January 2018. Women with urinary incontinence complaints were randomly divided into two groups. For the first group, the urodynamic test was done. Both groups were evaluated one month and six months after TOT surgery based on the results of the I-QOL questionnaire. Results: The mean I-QOL score was 83.9±3.3 in questionnaire group and 81.6±4.6 in urodynamic group one month after surgery with no statistically significant (P=0.052) difference. The quality of life score after 6 months was 87.2±4 in the questionnaire group and 85.4±3 in the urodynamic group with no statistically significant differences with each other (P=0.084). Conclusion: In this study, the urodynamic test only had additional information related to lower urinary tract symptoms and it did not have effects on improving the outcome of the surgery. The test only imposes economic burden. Therefore, the urodynamic test is not required before surgery in patients with urinary stress incontinence

scholarly journals Effect of Premicturitional Bladder Volume on the Accuracy of Sonographic Assessment of Post Void Residual Urine Volume Measurement by Transabdominal Ultrasonography

2019 ◽  
Vol 18 (1) ◽  
pp. 30-36
Author(s):  
Roshani Pathak ◽  
Sunil Pradhan ◽  
Abhushan Tuladhar ◽  
Amit Shrestha ◽  
Riwaz Acharya
Keyword(s):  
Urinary Tract ◽  
Lower Urinary Tract Symptoms ◽  
Lower Urinary Tract ◽  
Urine Volume ◽  
Bladder Volume ◽  
Residual Urine Volume ◽  
Residual Urine ◽  
Urinary Tract Symptoms ◽  
Significant Difference ◽  
Lower Urinary

Introduction: The Post Void Residual Urine volume (PVRU) is frequently significant in patients with bladder outflow obstruction; especially in patients with enlarged prostate and prostatism. The PVRU forms an important part of radiological investigation. Accurate measurement of the residual urine volume changes observed serially over a period of time may indicate clinical progress. The purpose of this study was to evaluate the effect of pre-void bladder volume on PVRU measurements. Methods: A prospective study was conducted to determine the accuracy of PVRU measurement in patient presenting with lower urinary tract symptoms (LUTS). 50 patients with LUTS were assessed ultrasonographically for pre void and post void bladder volumes during the study period of March 2017 till August 2017. PVRU measurements done in patients with bladder filling sensation at moderate to full capacity resulted in high estimations of PVRU which was quite significant in this study. Results: There was significant difference in the estimated PVRU between patients having high initial premicturitional volume (546±144 ml) than those with lower or moderate filling volume (261±58 ml) with mean of 173 ml and 35 ml respectively. The difference in estimated PVRU was highly significant with p value of < 0.0001. Conclusions: Measurement of pre void urinary bladder volume with an uncomfortably full bladder results in high post micturitional (PMRU) values even in most patients without lower urinary tract symptoms which may be false-positive. We advise that initial or pre-void urine volume be measured when the patient has initial or moderate feeling of bladder fullness.  

scholarly journals Alpha 1-Adrenoceptor Blocker May Improve Not Only Voiding But Also Storage Lower Urinary Tract Symptoms Caused by 125I Brachytherapy for Prostate Cancer

ISRN Urology ◽  
2014 ◽  
Vol 2014 ◽  
pp. 1-8 ◽  
Author(s):  
Nobuyuki Oyama ◽  
Yoshitaka Aoki ◽  
Hideaki Ito ◽  
Yoshiji Miwa ◽  
Hironobu Akino ◽  
...  
Keyword(s):  
Urinary Tract ◽  
Lower Urinary Tract Symptoms ◽  
Lower Urinary Tract ◽  
Urine Volume ◽  
External Beam Radiation ◽  
Prostate Brachytherapy ◽  
Beam Radiation ◽  
Urinary Tract Symptoms ◽  
Postvoid Residual Urine ◽  
Lower Urinary

Purpose. To assess changes in lower urinary tract symptoms (LUTS) within 1 year after brachytherapy in patients receiving alpha 1-adrenoceptor antagonists. Methods. We retrospectively evaluated 116 patients who underwent 125I prostate brachytherapy in our institute. Seventy-one patients were treated with a combination of external beam radiation therapy and brachytherapy. Alpha 1-adrenoceptor antagonists were prescribed to all patients after brachytherapy. International Prostate Symptom Score (IPSS) forms and postvoid residual urine volume were recorded at all follow-up visits. Results. Forty-nine patients were given tamsulosin hydrochloride, 32 were given silodosin hydrochloride, and 35 were given naftopidil for up to 6 months after seed implantation. Patients given tamsulosin or naftopidil tended to show a higher peak IPSS and slower recovery to baseline values than those given silodosin. The patients given naftopidil showed an insufficient recovery in storage symptoms in naftopidil group in comparison with tamsulosin group at 3 months and with silodosin group at 6 and 9 months. Conclusions. In the management of LUT after brachytherapy, silodosin may provide a more favorable improvement. Silodosin and tamsulosin may have an advantage in improving not only voiding but also storage lower urinary tract symptoms after brachytherapy.

Sign in / Sign up

Export Citation Format

Share Document